Lifeboat Foundation

Scientists at the University of Illinois Urbana-Champaign have developed a portable, self-powered ultraviolet-C device called the Tribo-sanitizer that can inactivate two of the bacteria responsible for many foodborne illnesses and deaths.

The Tribo-sanitizer’s UVC lamp is powered using the triboelectric effect —electricity that is generated when two dissimilar materials come into contact. In tests, the Tribo-sanitizer successfully inactivated two potentially deadly foodborne bacteria, Escherichia coli O157:H7, and Listeria monocytogenes, mainly by damaging their DNA, according to findings published in the journal Nano Energy.

The bacteria selected as testing targets are two of the most common causes of serious foodborne illness outbreaks in the U.S. Escherichia coli produces toxins that can cause severe abdominal cramps, fever, bloody diarrhea, and kidney failure, and Listeria monocytogenes can cause listeriosis, which has the highest rates of hospitalization and mortality of any foodborne illness.

https://www.youtube.com/watch?v=1-fNggTpGWQ

So if I heard this right, after 8 minutes or so, the effects are temporary and he indicates people would have to take this every couple of years.

Here Akshay talks about his interest in aging, how he met with Dr Katcher and formed Yuvan Research and their experiments with E5 and the results that they saw.
Some links are affiliate links so we will earn a commission when they are used to purchase products.

Continue reading “Reducing Biological Age By 67% : The Origins Of E5” »

Could a fecal transplant pill be the antidepressants of the future?

Depression is real, and it is complex. Most conditions that affect our brain chemistry are going to be complex, and there are no easy, simple answers. We can’t cure depression by just exercising more, eating better, or taking a short vacation to recharge (although there is some evidence that getting more money, especially to lift you out of poverty, helps relieve depressive symptoms).

French pharmaceutical technology company Aqemia has reached a multi-year research collaboration agreement valued at up to $140 million with industry giant Sanofi SA, according to a statement.

Experiments in orbit have shown the advantages of crystallizing valuable protein-based medicines in microgravity, possibly yielding new patents.

PARIS, Dec 5 (Reuters) — France raised the risk level of bird flu to ‘high’ from ‘moderate’ on Tuesday after new cases of the disease were detected, forcing poultry farms to keep birds indoors to stem the spread of the highly contagious virus.

The decision by the agriculture ministry was published in the Official Journal on Tuesday.

Avian influenza, commonly known as bird flu, has led to the culling of hundreds of millions birds worldwide in recent years.

No less sensitive for being mass produced, organoids are supporting applications such as drug development and providing an alternative to animal models.

Researchers using the new FLSHclust algorithm discovered 188 unique CRISPR-linked gene modules, including a novel type VII CRISPR-Cas system, in a massive protein database. This breakthrough enhances our understanding of CRISPR systems and their potential in biotechnological innovations.

Researchers have developed a new algorithm, FLSHclust (“flash clust”), leading to the discovery of 188 rare and previously unknown CRISPR-linked gene modules. This includes a novel type VII CRISPR-Cas system found among billions of protein sequences. The findings of this approach offer new possibilities for exploiting CRISPR systems and exploring the vast diversity of microbial proteins.

CRISPR’s Growing Impact in Biotechnology.

The flash drive of the future?